Global and United States Constipation Market Size, Status and Forecast 2020-2026

Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.
Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.

Market Analysis and Insights: Global Constipation Market
The global Constipation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Constipation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Constipation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Constipation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Constipation market.

Global Constipation Scope and Market Size
Constipation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Constipation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

Chronic Idiopathic Constipation (CIC)
Irritable Bowel Syndrome With Constipation (IBS-C)
Opioid-Induced Constipation (OIC)

Market segment by Application, split into

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Based on regional and country-level analysis, the Constipation market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Constipation market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

Takeda Pharmaceutical
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Bausch Health
Abbott
AstraZeneca
Cosmo Pharmaceuticals
Sanofi
Daewoong Pharmaceuticals
Bayer
Prestige Brands Holdings
Janssen Pharmaceutical
Shionogi
Albireo Pharma
Renexxion